Abstract
Efforts towards developing a vaccine for Middle East respiratory syndrome coronavirus (MERS-CoV) have yielded promising results. Utilizing a variety of platforms, several vaccine approaches have shown efficacy in animal models and begun to enter clinical trials. In this review, we summarize the current progress towards a MERS-CoV vaccine and highlight potential roadblocks identified from previous attempts to generate coronavirus vaccines.
Original language | English (US) |
---|---|
Article number | 74 |
Journal | Viruses |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2019 |
Keywords
- Animal models
- Coronavirus spike glycoprotein
- Correlates of immunity
- Middle East respiratory syndrome coronavirus
- Severe acute respiratory syndrome coronavirus
- Vaccine platforms
ASJC Scopus subject areas
- Infectious Diseases
- Virology